CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01031Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE1174.1533.35 (+2.92 %)
PREV CLOSE () 1140.80
OPEN PRICE () 1132.50
BID PRICE (QTY) 1173.35 (24)
OFFER PRICE (QTY) 1174.20 (32)
VOLUME 79807
TODAY'S LOW / HIGH ()1131.05 1181.40
52 WK LOW / HIGH ()1080.05 1414.4
NSE1171.8028.8 (+2.52 %)
PREV CLOSE() 1143.00
OPEN PRICE () 1130.00
BID PRICE (QTY) 1171.80 (12)
OFFER PRICE (QTY) 1171.90 (26)
VOLUME 1908638
TODAY'S LOW / HIGH() 1130.00 1182.00
52 WK LOW / HIGH ()1101 1414.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office :

Address : 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone : 040 - 4900 2900

Website : www.drreddys.com

Registrar's Details : Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, New York
NEWS
20Aug Dr Reddys Laboratories informs about n
Dr Reddys Laboratories has enclosed the copies of newspaper publication..
17Aug USFDA completes GMP inspection at Dr.
United States Food & Drug Administration (USFDA) has completed a GMP..
03Aug Dr. Reddy's Laboratories rises on gett
Dr. Reddy's Laboratories is currently trading at Rs. 1163.35, up by 15.7..
01Aug Dr. Reddy’s Laboratories informs about
Dr. Reddy’s Laboratories has informed that it enclosed a Press Release,..
01Aug Dr. Reddy's Laboratories gets USFDA’s
Dr. Reddy's Laboratories has received approval from U.S. Food and Drug A..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit404732197
Gross Profit 4970 42513
Operating Profit 887856070
Net Sales 51366205328
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25547.35 (1.09%)
M.Cap ( in Cr)
54281.24
Onesource Specialty (BSE)
 1594.40 (3.17%)
M.Cap ( in Cr)
18305.23
SMS Pharmaceuticals (BSE)
 463.10 (10.49%)
M.Cap ( in Cr)
4277.09
Procter&Gamble Healt (BSE)
 5460.00 (0.71%)
M.Cap ( in Cr)
9054.96
Torrent Pharma (BSE)
 4966.15 (0.77%)
M.Cap ( in Cr)
188890.68
Shareholding Pattern
PROMOTERS 26.64%
FI/BANKS/INSURANCE 15.33%
MUTUAL FUNDS/UTI 13.16%
NON-INSTITUTION 9.55%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74850.54-52.05 (-0.07%)
NIFTY23428.40-49.40 (-0.21%)
Dow Jones 52064.10-316.56 (-0.60%)
Nasdaq 26081.72-171.62 (-0.65%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI